Net Health is proud of all of our employees and team members. We attract some of the best and brightest in the industry, and their talents and expertise help us grow and innovate.
Kevin Keenahan is the VP of Strategy and Innovation at Net Health and the co-founder and CEO of Tissue Analytics (TA). Recently, he was featured in an ongoing series by Medium.Com – one of the world’s most widely read online media outlets – in Five Things I Wish Someone Told Me Before I Became A CEO.
Kevin highlighted how his early interest in technology and medicine led him to Johns Hopkins, where he met TA’s co-founder Josh Budman. While there, Josh and Kevin had the opportunity to see how chronic wounds were treated. Kevin noted, “for both of us, the experience changed the trajectory of our professional lives. We knew that there was an opportunity to make a real and impactful change for patients, providers, and the healthcare system as a whole.”
After developing the genesis for TA while in school and receiving considerable recognition for their innovative ideas, Josh and Kevin completed their Master’s at Johns Hopkins’ Center for Bioengineering Innovation & Design (CBID).
Soon after, they started Tissue Analytics. Josh and Kevin pioneered digital imaging for wound care, paving the way for the technology to revolutionize the way wounds are measured and treated. In 2020, they sold the company to Net Health (actually two years ago this month), where they both continue to play vital roles in product innovation and client services.
What does Kevin wish he knew before becoming a CEO? For one, that it’s important to start a company based on a problems-first and passion-priority approach. Starting a business that isn’t centered around solving a real-world problem or need is a losing strategy he notes.
Check out Five Things I Wish Someone Told Me Before I Became A CEO to find out more.